Latest news related to heart disease at Dorset Cardiologist.
The latest news related to heart disease supplied by Dorset Cardiologist, private and NHS cardiology services in Dorset covering Poole, Bournemouth and the surrounding area..
The angiotensin receptor–neprilysin inhibitor (LCZ696) was compared to the ACE inhibitor Enalapril in patients with systolic heart failure. All-cause mortality fell 16% on the novel agent. Follow-up averaged about 27 months. The study was published in the New England Journal of Medicine and the accompanying editorial stated the new agent "may prove to be the first disruptive agent to the heart-failure treatment algorithm, which has remained essentially unchanged for a decade".
The three currently licensed non-vitamin K antagonist oral anticoagulants (NOACs) – dabigatran, rivaroxaban and apixaban – have been approved by NICE as options for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation
A new randomised controlled trial of over 500 patients published in the New England Journal of Medicine has shown that renal denervation had no additional benefits over a sham procedure for reduction of blood pressure. This is in contrast to the previously published data without sham-controls suggesting benefit.
A study reported in the Journal of the American Medical Association links the amount of calories consumed from sugar to the risk of cardiovascular death.
The study suggests consuming seven or more sugar-containing beverages per week was associated with an increased risk of dying from cardiovascular disease.
Please check here for news related to developments in heart disease.
The BAMI trial is now under way investigating the use of stem cells injected after treatment for a heart attack.